2-Oxazolidinone → 3-{5-[4-(3,5-Dimethylpyridin-2-yl)piperazine-1-carbonyl]-3-methylpyridin-2-yl}-oxazolidin-2-one
Reaktionsgleichung
[CH3:1][C:2]1[C:3]([N:9]2[CH2:14][CH2:13][N:12]([C:15]([C:17]3[CH:18]=[N:19][C:20](F)=[C:21]([CH3:23])[CH:22]=3)=[O:16])[CH2:11][CH2:10]2)=[N:4][CH:5]=[C:6]([CH3:8])[CH:7]=1.[O:25]1[CH2:29][CH2:28][NH:27][C:26]1=[O:30]>>[CH3:1][C:2]1[C:3]([N:9]2[CH2:14][CH2:13][N:12]([C:15]([C:17]3[CH:22]=[C:21]([CH3:23])[C:20]([N:27]4[CH2:28][CH2:29][O:25][C:26]4=[O:30])=[N:19][CH:18]=3)=[O:16])[CH2:11][CH2:10]2)=[N:4][CH:5]=[C:6]([CH3:8])[CH:7]=1Komponenten
3
Versuchsvorschrift
By reaction and treatment in the same manner as in Example 240 and using [4-(3,5-dimethylpyridin-2-yl)piperazin-1-yl](6-fluoro-5-methylpyridin-3-yl)methanone (529 mg) described in Preparation Example 148 and oxazolidin-2-one (281 mg), the title compound (245 mg) was obtained.
Aufarbeitung
- customBy reaction and treatment in the same manner as in Example 240